https://www.headlinesoftoday.com/topic/press-releases/the-university-of-colorado-concludes-semaphorin-7a-in-vivo-study-with-global-cancer-technologys-drug-gct-007.html
THE UNIVERSITY OF COLORADO CONCLUDES SEMAPHORIN 7A IN VIVO STUDY WITH GLOBAL CANCER TECHNOLOGY’S DRUG, GCT-007